2016 ACBS Landline-Cellphone Combined Prevalence Tables

BRFSS Asthma Call-back Survey Prevalence TABLE 5b. Estimated percent reporting routine doctor visits in the past year among adults1 with active2 asthma by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.

Table 5B LLCP
State/Territory Sample
size±
One or more routine visits No routine visits3
Click here to skip to citation 3
Sample
size
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 353 209 55.3 4.8 (45.9 – 64.7) 144 44.7 4.8 (35.3 – 54.1)
California 263 122 39.5 4.0 (31.7 – 47.3) 141 60.5 4.0 (52.7 – 68.3)
Connecticut 314 204 58.2 4.3 (49.8 – 66.6) 110 41.8 4.3 (33.4 – 50.2)
Florida 952 564 53.9 3.7 (46.6 – 61.2) 388 46.1 3.7 (38.8 – 53.4)
Georgia 155 91 59.3 5.7 (48.1 – 70.5) 64 40.7 5.7 (29.5 – 51.9)
Hawaii 247 120 42.8 5.1 (32.8 – 52.8) 127 57.2 5.1 (47.2 – 67.2)
Illinois 175 109 56.8 5.2 (46.6 – 67.0) 66 43.2 5.2 (33.0 – 53.4)
Indiana 463 276 53.8 3.8 (46.4 – 61.2) 187 46.2 3.8 (38.8 – 53.6)
Iowa 188 122 54.4 5.5 (43.6 – 65.2) 66 45.6 5.5 (34.8 – 56.4)
Kansas 387 214 49.3 3.7 (42.0 – 56.6) 173 50.7 3.7 (43.4 – 58.0)
Maine 576 319 53.1 3.5 (46.2 – 60.0) 257 46.9 3.5 (40.0 – 53.8)
Massachusetts 209 127 57.8 5.2 (47.6 – 68.0) 82 42.2 5.2 (32.0 – 52.4)
Michigan 657 408 59.5 2.6 (54.4 – 64.6) 249 40.5 2.6 (35.4 – 45.6)
Minnesota 595 320 52.7 2.6 (47.6 – 57.8) 275 47.3 2.6 (42.2 – 52.4)
Missouri 277 173 58.4 5.7 (47.2 – 69.6) 104 41.6 5.7 (30.4 – 52.8)
Montana 192 105 53.2 5.6 (42.2 – 64.2) 87 46.8 5.6 (35.8 – 57.8)
Nebraska 466 251 47.4 4.3 (39.0 – 55.8) 215 52.6 4.3 (44.2 – 61.0)
Nevada 158 100 60.2 6.3 (47.9 – 72.5) 58 39.8 6.3 (27.5 – 52.1)
New Hampshire 220 131 62.5 4.8 (53.1 – 71.9) 89 37.5 4.8 (28.1 – 46.9)
New Jersey 285 172 55.9 6.7 (42.8 – 69.0) 113 44.1 6.7 (31.0 – 57.2)
New Mexico 207 126 62.9 5.1 (52.9 – 72.9) 81 37.1 5.1 (27.1 – 47.1)
New York 452 268 56.0 4.9 (46.4 – 65.6) 184 44.0 4.9 (34.4 – 53.6)
Ohio 446 264 60.0 3.6 (52.9 – 67.1) 182 40.0 3.6 (32.9 – 47.1)
Oklahoma 148 92 50.3 7.2 (36.2 – 64.4) 56 49.7 7.2 (35.6 – 63.8)
Oregon 161 79 51.1 4.6 (42.1 – 60.1) 82 48.9 4.6 (39.9 – 57.9)
Pennsylvania 262 158 58.6 4.6 (49.6 – 67.6) 104 41.4 4.6 (32.4 – 50.4)
Rhode Island 182 115 57.5 6.8 (44.2 – 70.8) 67 42.5 6.8 (29.2 – 55.8)
Texas 372 215 47.5 5.1 (37.5 – 57.5) 157 52.5 5.1 (42.5 – 62.5)
Utah 336 172 46.3 3.9 (38.7 – 53.9) 164 53.7 3.9 (46.1 – 61.3)
Vermont 241 139 53.2 4.8 (43.8 – 62.6) 102 46.8 4.8 (37.4 – 56.2)
Wisconsin 221 141 59.1 4.7 (49.9 – 68.3) 80 40.9 4.7 (31.7 – 50.1)
Puerto Rico 319 197 55.0 4.2 (46.8 – 63.2) 122 45.0 4.2 (36.8 – 53.2)
32 states / area 10,479 6,103 53.2 1.1 (51.0 – 55.4) 4,376 46.8 1.1 (44.6 – 49.0)
Median     55.2       44.9    
Range     39.5-62.9       37.1-60.5    

 
 

1 Aged ≥ 18 years

2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

3 No doctor visits or no routine doctor visits

± Landline and cell phone combined sample size excludes "DK/Refused"

§ Standard error

Confidence interval

Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon